Phio Pharmaceuticals Corp.
Records under this name other than the patents Phio Pharmaceuticals Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Back to Phio Pharmaceuticals Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,300,027 | Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition now held by Hapten Pharmaceuticals, LLC In force · High confidence | In force | High confidence | |
| US 8,815,818 | Phagocytic Cell Delivery of Rnai Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 10,041,073 | Reduced Size Self-Delivering Rnai Compounds Lapsed on the fee record Ended Aug 7, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 7, 2026 | Medium confidence |
| US 11,396,654 | Neutral Nanotransporters Lapsed on the fee record Ended Jul 26, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 26, 2026 | Medium confidence |
| US 9,963,702 | RNA Interference in Dermal and Fibrotic Indications Lapsed on the fee record Ended May 8, 2026 · High confidence | Lapsed on the fee record | Ended May 8, 2026 | High confidence |
| US 9,938,530 | RNA Interference in Skin Indications Lapsed on the fee record Ended Apr 10, 2026 · High confidence | Lapsed on the fee record | Ended Apr 10, 2026 | High confidence |
| US 11,279,934 | Methods for Treating Cancer Using Nucleic Acids Targeting MDM2 or Mycn Lapsed on the fee record Ended Mar 22, 2026 · High confidence | Lapsed on the fee record | Ended Mar 22, 2026 | High confidence |
| US 8,664,189 | RNA Interference in Skin Indications Lapsed on the fee record Ended Mar 4, 2026 · High confidence | Lapsed on the fee record | Ended Mar 4, 2026 | High confidence |
| US 11,254,940 | Inhibition of MAP4K4 Through Rnai Lapsed on the fee record Ended Feb 22, 2026 · Medium confidence | Lapsed on the fee record | Ended Feb 22, 2026 | Medium confidence |
| US 11,001,845 | Nucleic Acid Molecules Targeting Superoxide Dismutase 1 (SOD1) Lapsed on the fee record Ended May 11, 2025 · High confidence | Lapsed on the fee record | Ended May 11, 2025 | High confidence |